| Entry |
|
|---|
| Name |
Belagenpumatucel-L (USAN);
Lucanix (TN) |
|---|
| Efficacy |
Antineoplastic |
|---|
| Type |
Cellular therapy product |
|---|
| Comment |
Allogeneic vaccine cocktail of TGF-beta blocked, whole non-small cell lung cancer tumor cells.
Cell therapy treatment of non-small cell lung cancer
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04060 | Cytokine-cytokine receptor interaction |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Signaling molecules and receptors
Cytokines
Transforming growth factors (RSTK-binding)
TGFB2
D06563 Belagenpumatucel-L (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
